A Prospective Multicenter Non-randomized Controlled Study of Palliative Treatments for Patients With Advanced Hepatocellular Carcinoma
Phase of Trial: Phase IV
Latest Information Update: 05 Apr 2018
At a glance
- Drugs Sorafenib (Primary) ; Antineoplastics
- Indications Liver cancer
- Focus Therapeutic Use
- Acronyms 2011PTAHCC
- 13 Apr 2016 Planned End Date changed from 1 Jan 2016 to 1 Jan 2017.
- 04 Oct 2012 Planned end date changed from 1 Jan 2013 to 1 Jan 2016 as reported by ClinicalTrials.gov record.
- 09 Aug 2011 New trial record